OptimizeRx (OPRX) EBT (2010 - 2026)

OptimizeRx (OPRX) has 17 years of EBT data on file, last reported at -$644000.0 in Q1 2026.

• For the quarter ending Q1 2026, EBT rose 80.32% year-over-year to -$644000.0; the trailing twelve-month figure through Mar 2026 stood at $9.6 million (up 159.56% YoY), and the FY2025 full-year result was $7.0 million, up 135.85% from the prior year.
• EBT declined to -$644000.0 in Q1 2026, from $7.5 million in the prior quarter.
• In the past five years, EBT ranged from a high of $7.5 million in Q4 2025 to a low of -$11.7 million in Q4 2023.
• A 5-year average of -$2.9 million and a median of -$3.5 million in 2022 frame the typical range for EBT.
• Across the five-year window, EBT tumbled 8790.01% in 2022 and soared 238.36% in 2025, its largest moves.
• Tracing OPRX's EBT over 5 years: stood at -$325836.0 in 2022, then slumped by 3503.04% to -$11.7 million in 2023, then soared by 118.81% to $2.2 million in 2024, then soared by 238.36% to $7.5 million in 2025, then sank by 108.62% to -$644000.0 in 2026.
• Business Quant data shows OPRX's EBT at -$644000.0 in Q1 2026, $7.5 million in Q4 2025, and $1.0 million in Q3 2025.